nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—REN—Peptide hormone metabolism—TSHB—meningioma	0.0535	0.0535	CbGpPWpGaD
Captopril—MMP2—Collagen degradation—CTSL—meningioma	0.0519	0.0519	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—PLAUR—meningioma	0.0383	0.0383	CbGpPWpGaD
Captopril—MMP9—Osteopontin Signaling—PLAU—meningioma	0.0362	0.0362	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.0341	0.0341	CbGpPWpGaD
Captopril—MMP9—Collagen degradation—CTSL—meningioma	0.0341	0.0341	CbGpPWpGaD
Captopril—MMP2—Osteopontin-mediated events—PLAU—meningioma	0.0275	0.0275	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—PLAU—meningioma	0.0269	0.0269	CbGpPWpGaD
Captopril—MMP9—Assembly of collagen fibrils and other multimeric structures—CTSL—meningioma	0.0265	0.0265	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—CTSL—meningioma	0.0263	0.0263	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—PLAUR—meningioma	0.0251	0.0251	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.0239	0.0239	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—TSHB—meningioma	0.0239	0.0239	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—PDGFB—meningioma	0.0229	0.0229	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.0224	0.0224	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—meningioma	0.0202	0.0202	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—HES1—meningioma	0.0198	0.0198	CbGpPWpGaD
Captopril—F2—Blood Clotting Cascade—PLAU—meningioma	0.0184	0.0184	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—PLAU—meningioma	0.0181	0.0181	CbGpPWpGaD
Captopril—MMP9—Collagen formation—CTSL—meningioma	0.0181	0.0181	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—PLAU—meningioma	0.0176	0.0176	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—CTSL—meningioma	0.0172	0.0172	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—PLAUR—meningioma	0.0165	0.0165	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—PLAU—meningioma	0.0165	0.0165	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.0157	0.0157	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—meningioma	0.0142	0.0142	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—PLAUR—meningioma	0.0119	0.0119	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—PLAU—meningioma	0.0116	0.0116	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—CTSL—meningioma	0.011	0.011	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—PLAU—meningioma	0.0101	0.0101	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—TSHB—meningioma	0.0101	0.0101	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALAD—meningioma	0.00975	0.00975	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—PLAU—meningioma	0.00942	0.00942	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—PLAU—meningioma	0.00834	0.00834	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—AKT1—meningioma	0.00753	0.00753	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.00748	0.00748	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CTSL—meningioma	0.00722	0.00722	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—PLAUR—meningioma	0.00666	0.00666	CbGpPWpGaD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.00638	0.00638	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TSHB—meningioma	0.00628	0.00628	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—PTEN—meningioma	0.00555	0.00555	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PDGFB—meningioma	0.00554	0.00554	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—AKT1—meningioma	0.00524	0.00524	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—PDGFB—meningioma	0.00512	0.00512	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—AKT1—meningioma	0.00511	0.00511	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—TSHB—meningioma	0.00502	0.00502	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.0049	0.0049	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—PTEN—meningioma	0.00486	0.00486	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—AKT1—meningioma	0.00481	0.00481	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.00474	0.00474	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—TSHB—meningioma	0.00451	0.00451	CbGpPWpGaD
Captopril—F2—Platelet Aggregation (Plug Formation)—AKT1—meningioma	0.00411	0.00411	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PDGFB—meningioma	0.00409	0.00409	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—AKT1—meningioma	0.00393	0.00393	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00384	0.00384	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—meningioma	0.00379	0.00379	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—ERBB2—meningioma	0.00371	0.00371	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HES1—meningioma	0.00362	0.00362	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TSHB—meningioma	0.00361	0.00361	CbGpPWpGaD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.00358	0.00358	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—PLAUR—meningioma	0.00353	0.00353	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—meningioma	0.00344	0.00344	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—AKT1—meningioma	0.00343	0.00343	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—AKT1—meningioma	0.00343	0.00343	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—PDGFB—meningioma	0.00336	0.00336	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—AKT1—meningioma	0.00335	0.00335	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—meningioma	0.00331	0.00331	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—PLAUR—meningioma	0.00331	0.00331	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.00323	0.00323	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—PTEN—meningioma	0.00317	0.00317	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—SMO—meningioma	0.00307	0.00307	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—meningioma	0.00306	0.00306	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00299	0.00299	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—PLAUR—meningioma	0.00297	0.00297	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ERBB2—meningioma	0.00291	0.00291	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—AKT1—meningioma	0.00276	0.00276	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—PDGFB—meningioma	0.00267	0.00267	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00255	0.00255	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—TSHB—meningioma	0.00254	0.00254	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—meningioma	0.00249	0.00249	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HES1—meningioma	0.00238	0.00238	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00232	0.00232	CbGpPWpGaD
Captopril—F2—Hemostasis—PLAUR—meningioma	0.00213	0.00213	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00208	0.00208	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ERBB2—meningioma	0.00208	0.00208	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TSHB—meningioma	0.00204	0.00204	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ERBB2—meningioma	0.00191	0.00191	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TSHB—meningioma	0.00185	0.00185	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—AKT1—meningioma	0.00183	0.00183	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTEN—meningioma	0.00171	0.00171	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—PLAUR—meningioma	0.00168	0.00168	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—SMO—meningioma	0.00158	0.00158	CbGpPWpGaD
Captopril—F2—Hemostasis—PDGFB—meningioma	0.00154	0.00154	CbGpPWpGaD
Captopril—F2—Hemostasis—PLAU—meningioma	0.00149	0.00149	CbGpPWpGaD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.00142	0.00142	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSHB—meningioma	0.00142	0.00142	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—meningioma	0.00136	0.00136	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—meningioma	0.00122	0.00122	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMO—meningioma	0.00121	0.00121	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00119	0.00119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PGR—meningioma	0.00116	0.00116	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSHB—meningioma	0.0011	0.0011	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—AKT1—meningioma	0.00102	0.00102	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AKT1—meningioma	0.000986	0.000986	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000984	0.000984	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMO—meningioma	0.000931	0.000931	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000899	0.000899	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PGR—meningioma	0.000893	0.000893	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAUR—meningioma	0.000845	0.000845	CbGpPWpGaD
Captopril—ALB—Metabolism—ALAD—meningioma	0.000806	0.000806	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES1—meningioma	0.00079	0.00079	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000782	0.000782	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALAD—meningioma	0.000707	0.000707	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDGFB—meningioma	0.000676	0.000676	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—AKT1—meningioma	0.00067	0.00067	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000667	0.000667	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALAD—meningioma	0.000666	0.000666	CbGpPWpGaD
Captopril—ALB—Hemostasis—PDGFB—meningioma	0.000611	0.000611	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES1—meningioma	0.00061	0.00061	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—meningioma	0.000601	0.000601	CbGpPWpGaD
Captopril—ALB—Hemostasis—PLAU—meningioma	0.000593	0.000593	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFB—meningioma	0.000522	0.000522	CbGpPWpGaD
Captopril—ALB—Metabolism—TSHB—meningioma	0.00052	0.00052	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—meningioma	0.000507	0.000507	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TSHB—meningioma	0.000455	0.000455	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000455	0.000455	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—meningioma	0.000453	0.000453	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TSHB—meningioma	0.000429	0.000429	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00039	0.00039	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—meningioma	0.000386	0.000386	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000384	0.000384	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—meningioma	0.00035	0.00035	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—meningioma	0.000321	0.000321	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000318	0.000318	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—meningioma	0.000298	0.000298	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—meningioma	0.000291	0.000291	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—meningioma	0.000264	0.000264	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—meningioma	0.000238	0.000238	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—meningioma	0.000223	0.000223	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—meningioma	0.000204	0.000204	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—meningioma	0.000201	0.000201	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—meningioma	0.000172	0.000172	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—meningioma	0.000142	0.000142	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—meningioma	0.000124	0.000124	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—meningioma	0.000117	0.000117	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—meningioma	8.16e-05	8.16e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—meningioma	7.15e-05	7.15e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—meningioma	6.74e-05	6.74e-05	CbGpPWpGaD
